Foley Hoag was proud to sponsor the 2024 Biotechnology Innovation Organization (BIO) International Convention, the industry’s preeminent conference representing the full biotech ecosystem from across the globe. Foley Hoag Partners
Thomas Barker and
Christopher Escobedo Hart both spoke as part of the conference.
Tom moderated a panel discussion on "A Perspective from the Trenches: Challenges of Budgeting for Gene Therapies, Innovative Payment Systems That Work for Medicaid Departments and Patients, and What the States Need from CMS." The presentation explored the prospects and obstacles around these revolutionary, but costly, therapies, including:
- how state Medicaid agencies will address the budgeting challenges that the new therapies pose
- what payment models will facilitate broader use of cell and gene therapie
- what potential actions the U.S. Centers for Medicare & Medicaid Services can take to encourage wider adoption
Chris joined a panel organized by the Alliance for Artificial Intelligence in Healthcare (AAIH) for a discussion on "AI and Regulatory Innovation in Healthcare: Shaping the Future," which worked through a SWOT analysis to explore the pivotal role of artificial intelligence in regulatory innovation. The panel shared how AI is reshaping healthcare regulations, and uncovered the potential benefits, challenges and regulatory implications of AI adoption in healthcare.
To read AAHI's full SWOT analysis, please click here.
